MDXH News

Mdxhealth to Release Second Quarter 2026 Financial Results on August 13

Mdxhealth Announces Receipt of Nasdaq Notification Regarding Minimum Market Value of Listed Securities Deficiency

Mdxhealth Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency

Mdxhealth Announces Peer-Reviewed Publication of Oxford GPS-ProMPT Study in European Urology Oncology, Establishing Scientific Foundation for the Landmark GPS-ProtecT Randomized Controlled Trial

Mdxhealth Reports Q1-2026 Results

Mdxhealth to Release First Quarter 2026 Financial Results on May 13

Liquid Biopsy Products Market Report 2026-2031 Featuring Analysis of Roche, Illumina, Qiagen, MDxHealth, Novogen, BGI, Myriad Genetics and More

Mdxhealth Highlights Data from Oxford’s ProMPT Study Demonstrating the Genomic Prostate Score GPS Test Predicts Adverse Outcomes Across Multiple Treatment Settings at EAU 2026

Mdxhealth Announces Fourth Quarter and Full-Year 2025 Financial Results

Mdxhealth to Present Fourth Quarter and Full Year 2025 Financial Results and Corporate Update on February 26